Most people are surprised to learn that rigorous application of formal rules of evidence to evaluate medical research and decide on the best treatments is a recent phenomenon. They might be just as surprised to learn that health policy is not yet subject to the same approach.
Most people are surprised to learn that rigorous application of formal rules of evidence to evaluate medical research and decide on the best treatments is a recent phenomenon. They might be just as surprised to learn that health policy is not yet subject to the same approach.
So-called “evidence-based medicine” entails a hierarchy of empirical proof that ranks medical studies according to their quality. Physiological research on animals, or of human responses in laboratory settings, rank low on the hierarchy. Observational studies that compare outcomes for patients who receive particular treatments and control subject who do not rank higher, but may still be misleading.
Convincing studies of drugs and surgical procedures usually come only from randomized trials, in which patients receive treatment or don’t according to a process analogous to a coin flip. Well-conducted randomized trials incorporate additional safeguards against bias, including use of placebo medication that allows investigators to blind patients and caregivers to whether patients are, or are not, receiving active treatment.
To continue reading, register now.
Subscribe now for unlimited access to everything PS has to offer.
With a likely rematch between Joe Biden and Donald Trump in the 2024 US presidential election, America and the rest of the world were heading into a perilous period even before the latest conflagration in the Middle East. Turmoil in the region will cloud the broader economic outlook – and could dim Biden’s chances.
worries global economic and political developments will put Donald Trump back in the White House.
Around the world, foreign-policy strategists are grappling with new international dynamics, from the Sino-American rivalry and ongoing hot wars to the broader breakdown in multilateral global governance. However, there is much debate about whether global power and alignments are truly shifting, and in what ways.
consider whether the world will become more multipolar or “non-aligned” in the new year.
It is hard to see anything good coming from the current spasm of violence between Israel and Hamas. But this tragedy, which has forced both Israelis and Palestinians to stare into the abyss, might prove to be a turning point that will clear the path for a lasting peace.
considers how the current conflagration might pave the way for a solution to the Israeli-Palestinian conflict.
Most people are surprised to learn that rigorous application of formal rules of evidence to evaluate medical research and decide on the best treatments is a recent phenomenon. They might be just as surprised to learn that health policy is not yet subject to the same approach.
So-called “evidence-based medicine” entails a hierarchy of empirical proof that ranks medical studies according to their quality. Physiological research on animals, or of human responses in laboratory settings, rank low on the hierarchy. Observational studies that compare outcomes for patients who receive particular treatments and control subject who do not rank higher, but may still be misleading.
Convincing studies of drugs and surgical procedures usually come only from randomized trials, in which patients receive treatment or don’t according to a process analogous to a coin flip. Well-conducted randomized trials incorporate additional safeguards against bias, including use of placebo medication that allows investigators to blind patients and caregivers to whether patients are, or are not, receiving active treatment.
To continue reading, register now.
Subscribe now for unlimited access to everything PS has to offer.
Subscribe
As a registered user, you can enjoy more PS content every month – for free.
Register
Already have an account? Log in